MGIA
TEVA icon

Moneta Group Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Moneta Group Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100,649
Closed -$1.24M – 292
2020
Q2 		$1.24M Sell
100,649
-1,578
-2% -$17.8K 0.12% 103
2020
Q1 		$918K Buy
+102,227
New +$1.05M 0.1% 114
2018
Q2 		– Sell
-1,000
Closed -$17K – 620
2018
Q1 		$17K Buy
+1,000
New +$19.5K ﹤0.01% 417
2017
Q1 		– Sell
-6,572
Closed -$238K – 173
2016
Q4 		$238K Buy
+6,572
New +$262K 0.05% 147
2016
Q3 		– Sell
-16,835
Closed -$846K – 157
2016
Q2 		$846K Buy
16,835
+1,721
+11% +$91.6K 0.19% 76
2016
Q1 		$809K Buy
15,114
+7,089
+88% +$416K 0.18% 73
2015
Q4 		$527K Sell
8,025
-4,774
-37% -$295K 0.13% 73
2015
Q3 		$723K Sell
12,799
-231
-2% -$15K 0.2% 53
2015
Q2 		$770K Buy
13,030
+1,160
+10% +$71.6K 0.24% 51
2015
Q1 		$740K Buy
11,870
+3,280
+38% +$191K 0.32% 64
2014
Q4 		$494K Buy
8,590
+2,515
+41% +$140K 0.24% 76
2014
Q3 		$327K Buy
+6,075
New +$322K 0.17% 99

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Moneta Group Investment Advisors's TEVA Position: Q3 2020 in Review

Moneta Group Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 100,649 shares — an estimated $1.24M sold.

Moneta Group Investment Advisors first reported a position in TEVA in Q3 2014 and held it in 12 quarters. The position peaked at $1.24M in Q2 2020. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Moneta Group Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 100,649 Teva Pharmaceuticals shares in Q3 2020, an estimated $1.24M.
  • Moneta Group Investment Advisors first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 12 quarters.
  • Moneta Group Investment Advisors's Teva Pharmaceuticals position peaked at $1.24M in Q2 2020.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Moneta Group Investment Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.